{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T17:23:22Z","timestamp":1787765002379,"version":"build-2784847793"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T00:00:00Z","timestamp":1731369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T00:00:00Z","timestamp":1731369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271112"],"award-info":[{"award-number":["82271112"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271112"],"award-info":[{"award-number":["82271112"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"DOI":"10.1007\/s10792-024-03338-9","type":"journal-article","created":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T14:48:10Z","timestamp":1731422890000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Review on classification of polypoidal choroidal vasculopathy"],"prefix":"10.1007","volume":"44","author":[{"given":"Wenfei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youxin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,12]]},"reference":[{"issue":"5","key":"3338_CR1","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.ophtha.2017.11.019","volume":"125","author":"CMG Cheung","year":"2018","unstructured":"Cheung CMG, Lai TYY, Ruamviboonsuk P et al (2018) Polypoidal choroidal vasculopathy: definition, pathogenesis, diagnosis, and management. Ophthalmology 125(5):708\u2013724. https:\/\/doi.org\/10.1016\/j.ophtha.2017.11.019","journal-title":"Ophthalmology"},{"issue":"3","key":"3338_CR2","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.ophtha.2020.08.006","volume":"128","author":"CMG Cheung","year":"2021","unstructured":"Cheung CMG, Lai TYY, Teo K et al (2021) Polypoidal choroidal vasculopathy: consensus nomenclature and non-indocyanine green angiograph diagnostic criteria from the Asia-Pacific ocular imaging society PCV workgroup. Ophthalmology 128(3):443\u2013452. https:\/\/doi.org\/10.1016\/j.ophtha.2020.08.006","journal-title":"Ophthalmology"},{"issue":"2","key":"3338_CR3","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1097\/APO.0000000000000573","volume":"12","author":"P Ruamviboonsuk","year":"2023","unstructured":"Ruamviboonsuk P, Lai TYY, Chen SJ et al (2023) Polypoidal choroidal vasculopathy: updates on risk factors, diagnosis, and treatments. Asia Pac J Ophthalmol (Phila) 12(2):184\u2013195. https:\/\/doi.org\/10.1097\/APO.0000000000000573","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"issue":"11","key":"3338_CR4","doi-asserted-by":"publisher","first-page":"4729","DOI":"10.1167\/iovs.08-2134","volume":"49","author":"H Nakashizuka","year":"2008","unstructured":"Nakashizuka H, Mitsumata M, Okisaka S et al (2008) Clinicopathologic findings in polypoidal choroidal vasculopathy. Invest Ophthalmol Vis Sci 49(11):4729\u20134737. https:\/\/doi.org\/10.1167\/iovs.08-2134","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"3338_CR5","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1136\/bjo.86.3.321","volume":"86","author":"H Terasaki","year":"2002","unstructured":"Terasaki H, Miyake Y, Suzuki T et al (2002) Polypoidal choroidal vasculopathy treated with macular translocation: clinical pathological correlation. Br J Ophthalmol 86(3):321\u2013327. https:\/\/doi.org\/10.1136\/bjo.86.3.321","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"3338_CR6","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.ajo.2005.10.012","volume":"141","author":"JP Tong","year":"2006","unstructured":"Tong JP, Chan WM, Liu DT et al (2006) Aqueous humor levels of vascular endothelial growth factor and pigment epithelium-derived factor in polypoidal choroidal vasculopathy and choroidal neovascularization. Am J Ophthalmol 141(3):456\u2013462. https:\/\/doi.org\/10.1016\/j.ajo.2005.10.012","journal-title":"Am J Ophthalmol"},{"issue":"11","key":"3338_CR7","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1001\/jamaophthalmol.2017.4030","volume":"135","author":"A Koh","year":"2017","unstructured":"Koh A, Lai TYY, Takahashi K et al (2017) Efficacy and safety of ranibizumab with or without verteporfin photodynamic therapy for polypoidal choroidal vasculopathy: a randomized clinical trial. JAMA Ophthalmol 135(11):1206\u20131213. https:\/\/doi.org\/10.1001\/jamaophthalmol.2017.4030","journal-title":"JAMA Ophthalmol"},{"issue":"7","key":"3338_CR8","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1001\/jamaophthalmol.2018.1804","volume":"136","author":"WK Lee","year":"2018","unstructured":"Lee WK, Iida T, Ogura Y et al (2018) Efficacy and safety of intravitreal aflibercept for polypoidal choroidal vasculopathy in the PLANET study: a randomized clinical trial. JAMA Ophthalmol 136(7):786\u2013793. https:\/\/doi.org\/10.1001\/jamaophthalmol.2018.1804","journal-title":"JAMA Ophthalmol"},{"issue":"8","key":"3338_CR9","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1016\/j.ophtha.2003.12.056","volume":"111","author":"WM Chan","year":"2004","unstructured":"Chan WM, Lam DS, Lai TY et al (2004) Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series. Ophthalmology 111(8):1576\u20131584. https:\/\/doi.org\/10.1016\/j.ophtha.2003.12.056","journal-title":"Ophthalmology"},{"issue":"5","key":"3338_CR10","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/s0002-9394(02)01404-6","volume":"133","author":"M Uyama","year":"2002","unstructured":"Uyama M, Wada M, Nagai Y et al (2002) Polypoidal choroidal vasculopathy: natural history. Am J Ophthalmol 133(5):639\u2013648. https:\/\/doi.org\/10.1016\/s0002-9394(02)01404-6","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"3338_CR11","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/IAE.0b013e318188c839","volume":"29","author":"P Cackett","year":"2009","unstructured":"Cackett P, Wong D, Yeo I (2009) A classification system for polypoidal choroidal vasculopathy. Retina 29(2):187\u2013191. https:\/\/doi.org\/10.1097\/IAE.0b013e318188c839","journal-title":"Retina"},{"issue":"4","key":"3338_CR12","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s00417-007-0680-8","volume":"246","author":"A Okubo","year":"2008","unstructured":"Okubo A, Hirakawa M, Ito M et al (2008) Clinical features of early and late stage polypoidal choroidal vasculopathy characterized by lesion size and disease duration. Graefes Arch Clin Exp Ophthalmol 246(4):491\u2013499. https:\/\/doi.org\/10.1007\/s00417-007-0680-8","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"12","key":"3338_CR13","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1097\/IAE.0000000000000255","volume":"34","author":"CM Cheung","year":"2014","unstructured":"Cheung CM, Lai TY, Chen SJ et al (2014) Understanding indocyanine green angiography in polypoidal choroidal vasculopathy: the group experience with digital fundus photography and confocal scanning laser ophthalmoscopy. Retina 34(12):2397\u20132406. https:\/\/doi.org\/10.1097\/IAE.0000000000000255","journal-title":"Retina"},{"issue":"5","key":"3338_CR14","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1136\/bjo.2004.049296","volume":"89","author":"M Yuzawa","year":"2005","unstructured":"Yuzawa M, Mori R, Kawamura A (2005) The origins of polypoidal choroidal vasculopathy. Br J Ophthalmol 89(5):602\u2013607. https:\/\/doi.org\/10.1136\/bjo.2004.049296","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"3338_CR15","doi-asserted-by":"publisher","first-page":"3998","DOI":"10.1167\/iovs.15-17207","volume":"56","author":"M Yuzawa","year":"2015","unstructured":"Yuzawa M (2015) Two subtypes of polypoidal choroidal vasculopathy: idiopathic disease or age-related macular degeneration. Invest Ophthalmol Vis Sci 56(6):3998. https:\/\/doi.org\/10.1167\/iovs.15-17207","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"3338_CR16","doi-asserted-by":"publisher","first-page":"7441","DOI":"10.1167\/iovs.11-7546","volume":"52","author":"K Tanaka","year":"2011","unstructured":"Tanaka K, Nakayama T, Mori R et al (2011) Associations of complement factor H (CFH) and age-related maculopathy susceptibility 2 (ARMS2) genotypes with subtypes of polypoidal choroidal vasculopathy. Invest Ophthalmol Vis Sci 52(10):7441\u20137444. https:\/\/doi.org\/10.1167\/iovs.11-7546","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"3338_CR17","doi-asserted-by":"publisher","first-page":"e474","DOI":"10.1111\/aos.12110","volume":"91","author":"A Kawamura","year":"2013","unstructured":"Kawamura A, Yuzawa M, Mori R et al (2013) Indocyanine green angiographic and optical coherence tomographic findings support classification of polypoidal choroidal vasculopathy into two types. Acta Ophthalmol 91(6):e474\u2013e481. https:\/\/doi.org\/10.1111\/aos.12110","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"3338_CR18","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1136\/bjophthalmol-2016-309264","volume":"101","author":"K Tanaka","year":"2017","unstructured":"Tanaka K, Mori R, Kawamura A et al (2017) Comparison of OCT angiography and indocyanine green angiographic findings with subtypes of polypoidal choroidal vasculopathy. Br J Ophthalmol 101(1):51\u201355. https:\/\/doi.org\/10.1136\/bjophthalmol-2016-309264","journal-title":"Br J Ophthalmol"},{"key":"3338_CR19","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.2147\/OPTH.S160961","volume":"12","author":"S Sakamoto","year":"2018","unstructured":"Sakamoto S, Takahashi H, Inoue Y et al (2018) Intravitreal aflibercept for exudative age-related macular degeneration with good visual acuity: 2-year results of a prospective study. Clin Ophthalmol 12:1137\u20131147. https:\/\/doi.org\/10.2147\/OPTH.S160961","journal-title":"Clin Ophthalmol"},{"issue":"11","key":"3338_CR20","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1097\/IAE.0000000000001845","volume":"38","author":"JH Kim","year":"2018","unstructured":"Kim JH, Chang YS, Kim JW et al (2018) Morphologic features associated with fibrotic scarring after anti-vascular endothelial growth factor therapy in polypoidal choroidal vasculopatHY. Retina 38(11):2168\u20132176. https:\/\/doi.org\/10.1097\/IAE.0000000000001845","journal-title":"Retina"},{"issue":"3","key":"3338_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0120643","volume":"10","author":"S Yanagisawa","year":"2015","unstructured":"Yanagisawa S, Sakurada Y, Miki A et al (2015) The association of elastin gene variants with two angiographic subtypes of polypoidal choroidal vasculopathy. PLoS ONE 10(3):e0120643. https:\/\/doi.org\/10.1371\/journal.pone.0120643","journal-title":"PLoS ONE"},{"issue":"3","key":"3338_CR22","doi-asserted-by":"publisher","first-page":"146","DOI":"10.3109\/13816810.2012.749288","volume":"34","author":"A Miki","year":"2013","unstructured":"Miki A, Honda S, Kondo N et al (2013) The association of age-related maculopathy susceptibility 2 (ARMS2) and complement factor H (CFH) variants with two angiographic subtypes of polypoidal choroidal vasculopathy. Ophthalmic Genet 34(3):146\u2013150. https:\/\/doi.org\/10.3109\/13816810.2012.749288","journal-title":"Ophthalmic Genet"},{"issue":"2","key":"3338_CR23","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1159\/000360308","volume":"232","author":"S Honda","year":"2014","unstructured":"Honda S, Miki A, Yanagisawa S et al (2014) Comparison of the outcomes of photodynamic therapy between two angiographic subtypes of polypoidal choroidal vasculopathy. Ophthalmologica 232(2):92\u201396. https:\/\/doi.org\/10.1159\/000360308","journal-title":"Ophthalmologica"},{"issue":"6","key":"3338_CR24","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1136\/bjophthalmol-2016-309144","volume":"101","author":"S Jeong","year":"2017","unstructured":"Jeong S, Sagong M (2017) Short-term efficacy of intravitreal aflibercept depending on angiographic classification of polypoidal choroidal vasculopathy. Br J Ophthalmol 101(6):758\u2013763. https:\/\/doi.org\/10.1136\/bjophthalmol-2016-309144","journal-title":"Br J Ophthalmol"},{"issue":"21","key":"3338_CR25","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.4103\/0366-6999.192779","volume":"129","author":"Y Cheng","year":"2016","unstructured":"Cheng Y, Shi X, Qu JF et al (2016) Comparison of the 1-year outcomes of conbercept therapy between two different angiographic subtypes of polypoidal choroidal vasculopathy. Chin Med J (Engl) 129(21):2610\u20132616. https:\/\/doi.org\/10.4103\/0366-6999.192779","journal-title":"Chin Med J (Engl)"},{"issue":"2","key":"3338_CR26","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/IAE.0000000000001556","volume":"38","author":"L Yeung","year":"2018","unstructured":"Yeung L, Kuo CN, Chao AN et al (2018) angiographic subtypes of polypoidal choroidal vasculopathy in Taiwan: a prospective multicenter study. Retina 38(2):263\u2013271. https:\/\/doi.org\/10.1097\/IAE.0000000000001556","journal-title":"Retina"},{"issue":"11","key":"3338_CR27","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1136\/bjophthalmol-2014-305059","volume":"98","author":"CS Tan","year":"2014","unstructured":"Tan CS, Ngo WK, Lim LW et al (2014) A novel classification of the vascular patterns of polypoidal choroidal vasculopathy and its relation to clinical outcomes. Br J Ophthalmol 98(11):1528\u20131533. https:\/\/doi.org\/10.1136\/bjophthalmol-2014-305059","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"3338_CR28","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1167\/iovs.17-22683","volume":"59","author":"CS Tan","year":"2018","unstructured":"Tan CS, Lim LW, Ngo WK et al (2018) Everest report 5: clinical outcomes and treatment response of polypoidal choroidal vasculopathy subtypes in a multicenter, randomized controlled trial. Invest Ophthalmol Vis Sci 59(2):889\u2013896. https:\/\/doi.org\/10.1167\/iovs.17-22683","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"3338_CR29","doi-asserted-by":"publisher","first-page":"3187","DOI":"10.1167\/iovs.14-16236","volume":"56","author":"G Coscas","year":"2015","unstructured":"Coscas G, Lupidi M, Coscas F et al (2015) Toward a specific classification of polypoidal choroidal vasculopathy: idiopathic disease or subtype of age-related macular degeneration. Invest Ophthalmol Vis Sci 56(5):3187\u20133195. https:\/\/doi.org\/10.1167\/iovs.14-16236","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"3338_CR30","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s00417-020-04844-z","volume":"259","author":"EHC van Dijk","year":"2021","unstructured":"van Dijk EHC, Mohabati D, Veselinovic S et al (2021) The spectrum of polypoidal choroidal vasculopathy in Caucasians: clinical characteristics and proposal of a classification. Graefes Arch Clin Exp Ophthalmol 259(2):351\u2013361. https:\/\/doi.org\/10.1007\/s00417-020-04844-z","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"11","key":"3338_CR31","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1097\/IAE.0000000000000777","volume":"35","author":"M Inoue","year":"2015","unstructured":"Inoue M, Balaratnasingam C, Freund KB (2015) Optical coherence tomography angiography of polypoidal choroidal vasculopathy and polypoidal choroidal neovascularization. Retina 35(11):2265\u20132274. https:\/\/doi.org\/10.1097\/IAE.0000000000000777","journal-title":"Retina"},{"issue":"10","key":"3338_CR32","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1097\/IAE.0000000000002259","volume":"39","author":"JW Jang","year":"2019","unstructured":"Jang JW, Kim JM, Kang SW et al (2019) Typical polypoidal choroidal vasculopathy and polypoidal choroidal neovascularization. Retina 39(10):1995\u20132003. https:\/\/doi.org\/10.1097\/IAE.0000000000002259","journal-title":"Retina"},{"issue":"1","key":"3338_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/IAE.0000000000000774","volume":"36","author":"C Balaratnasingam","year":"2016","unstructured":"Balaratnasingam C, Lee WK, Koizumi H et al (2016) Polypoidal choroidal vasculopathy: a distinct disease or manifestation of many? Retina 36(1):1\u20138. https:\/\/doi.org\/10.1097\/IAE.0000000000000774","journal-title":"Retina"},{"issue":"1","key":"3338_CR34","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41433-018-0158-4","volume":"33","author":"CMG Cheung","year":"2019","unstructured":"Cheung CMG, Lee WK, Koizumi H et al (2019) Pachychoroid disease. Eye (Lond) 33(1):14\u201333. https:\/\/doi.org\/10.1038\/s41433-018-0158-4","journal-title":"Eye (Lond)"},{"issue":"4","key":"3338_CR35","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/s41433-023-02764-w","volume":"38","author":"CMG Cheung","year":"2024","unstructured":"Cheung CMG (2024) Macular neovascularization and polypoidal choroidal vasculopathy: phenotypic variations, pathogenic mechanisms and implications in management. Eye (Lond) 38(4):659\u2013667. https:\/\/doi.org\/10.1038\/s41433-023-02764-w","journal-title":"Eye (Lond)"},{"key":"3338_CR36","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.preteyeres.2016.04.002","volume":"53","author":"CW Wong","year":"2016","unstructured":"Wong CW, Yanagi Y, Lee WK et al (2016) Age-related macular degeneration and polypoidal choroidal vasculopathy in Asians. Prog Retin Eye Res 53:107\u2013139. https:\/\/doi.org\/10.1016\/j.preteyeres.2016.04.002","journal-title":"Prog Retin Eye Res"},{"issue":"6","key":"3338_CR37","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.ajo.2015.08.028","volume":"160","author":"KK Dansingani","year":"2015","unstructured":"Dansingani KK, Balaratnasingam C, Klufas MA et al (2015) Optical coherence tomography angiography of shallow irregular pigment epithelial detachments in pachychoroid spectrum disease. Am J Ophthalmol 160(6):1243-1254.e2. https:\/\/doi.org\/10.1016\/j.ajo.2015.08.028","journal-title":"Am J Ophthalmol"},{"issue":"Suppl 1","key":"3338_CR38","doi-asserted-by":"publisher","first-page":"S73","DOI":"10.1097\/IAE.0000000000001346","volume":"36","author":"WK Lee","year":"2016","unstructured":"Lee WK, Baek J, Dansingani KK et al (2016) Choroidal morphology in eyes with polypoidal choroidal vasculopathy and normal or subnormal subfoveal choroidal thicknesS. Retina 36(Suppl 1):S73\u2013S82. https:\/\/doi.org\/10.1097\/IAE.0000000000001346","journal-title":"Retina"},{"issue":"1","key":"3338_CR39","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.ophtha.2012.07.048","volume":"120","author":"WB Wei","year":"2013","unstructured":"Wei WB, Xu L, Jonas JB et al (2013) Subfoveal choroidal thickness: the Beijing eye study. Ophthalmology 120(1):175\u2013180. https:\/\/doi.org\/10.1016\/j.ophtha.2012.07.048","journal-title":"Ophthalmology"},{"issue":"12","key":"3338_CR40","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1097\/IAE.0000000000001481","volume":"37","author":"P Gupta","year":"2017","unstructured":"Gupta P, Ting DSW, Thakku SG et al (2017) detailed characterization of choroidal morphologic and vascular features in age-related macular degeneration and polypoidal choroidal vasculopathy. Retina 37(12):2269\u20132280. https:\/\/doi.org\/10.1097\/IAE.0000000000001481","journal-title":"Retina"},{"issue":"7","key":"3338_CR41","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1097\/IAE.0000000000002583","volume":"40","author":"YC Chang","year":"2020","unstructured":"Chang YC, Cheng CK (2020) Difference between pachychoroid and nonpachychoroid polypoidal choroidal vasculopathy and their response to anti-vascular endothelial growth factor therapy. Retina 40(7):1403\u20131411. https:\/\/doi.org\/10.1097\/IAE.0000000000002583","journal-title":"Retina"},{"issue":"5","key":"3338_CR42","doi-asserted-by":"publisher","first-page":"731","DOI":"10.18240\/ijo.2020.05.06","volume":"13","author":"ZY Liu","year":"2020","unstructured":"Liu ZY, Li B, Xia S et al (2020) Analysis of choroidal morphology and comparison of imaging findings of subtypes of polypoidal choroidal vasculopathy: a new classification system. Int J Ophthalmol 13(5):731\u2013736. https:\/\/doi.org\/10.18240\/ijo.2020.05.06","journal-title":"Int J Ophthalmol"},{"issue":"1","key":"3338_CR43","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s10792-020-01555-6","volume":"41","author":"R Venkatesh","year":"2021","unstructured":"Venkatesh R, Gadde SGK, Pereira A et al (2021) Impact of sub-foveal choroidal thickness on clinical features and long-term clinical outcomes in polypoidal choroidal vasculopathy. Int Ophthalmol 41(1):87\u201397. https:\/\/doi.org\/10.1007\/s10792-020-01555-6","journal-title":"Int Ophthalmol"},{"issue":"9","key":"3338_CR44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0184058","volume":"12","author":"M Kong","year":"2017","unstructured":"Kong M, Kim SM, Ham DI (2017) Comparison of clinical features and 3-month treatment response among three different choroidal thickness groups in polypoidal choroidal vasculopathy. PLoS ONE 12(9):e0184058. https:\/\/doi.org\/10.1371\/journal.pone.0184058","journal-title":"PLoS ONE"},{"issue":"11","key":"3338_CR45","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1097\/IAE.0000000000002723","volume":"40","author":"J Baek","year":"2020","unstructured":"Baek J, Lee JH, Lee K et al (2020) Clinical outcome of polypoidal choroidal vasculopathy\/aneurysmal type 1 neovascularization according to choroidal vascular morphology. Retina 40(11):2166\u20132174. https:\/\/doi.org\/10.1097\/IAE.0000000000002723","journal-title":"Retina"},{"issue":"9","key":"3338_CR46","doi-asserted-by":"publisher","first-page":"OCT526","DOI":"10.1167\/iovs.15-18955","volume":"57","author":"M Wang","year":"2016","unstructured":"Wang M, Zhou Y, Gao SS et al (2016) Evaluating polypoidal choroidal vasculopathy with optical coherence tomography angiography. Invest Ophthalmol Vis Sci 57(9):OCT526\u2013OCT532. https:\/\/doi.org\/10.1167\/iovs.15-18955","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"3338_CR47","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/s41598-018-37384-y","volume":"9","author":"CH Huang","year":"2019","unstructured":"Huang CH, Yeh PT, Hsieh YT et al (2019) Characterizing branching vascular network morphology in polypoidal choroidal vasculopathy by optical coherence tomography angiography. Sci Rep 9(1):595. https:\/\/doi.org\/10.1038\/s41598-018-37384-y","journal-title":"Sci Rep"},{"issue":"1","key":"3338_CR48","doi-asserted-by":"publisher","first-page":"17848","DOI":"10.1038\/s41598-021-97340-1","volume":"11","author":"ST Ma","year":"2021","unstructured":"Ma ST, Huang CH, Chang YC et al (2021) Clinical features and prognosis of polypoidal choroidal vasculopathy with different morphologies of branching vascular network on optical coherence tomography angiography. Sci Rep 11(1):17848. https:\/\/doi.org\/10.1038\/s41598-021-97340-1","journal-title":"Sci Rep"},{"issue":"3","key":"3338_CR49","doi-asserted-by":"publisher","first-page":"742","DOI":"10.3390\/jcm12030742","volume":"12","author":"L Chen","year":"2023","unstructured":"Chen L, Yuan M, Sun L et al (2023) Different morphology of branching neovascular network in polypoidal choroidal vasculopathy: a swept-source optical coherence tomography angiography study. J Clin Med 12(3):742. https:\/\/doi.org\/10.3390\/jcm12030742","journal-title":"J Clin Med"},{"issue":"2","key":"3338_CR50","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.oret.2023.11.001","volume":"8","author":"KYC Teo","year":"2024","unstructured":"Teo KYC, Zhao JZ, Klose G et al (2024) Polypoidal choroidal vasculopathy: evaluation based on 3-dimensional reconstruction of OCT angiography. Ophthalmol Retina 8(2):98\u2013107. https:\/\/doi.org\/10.1016\/j.oret.2023.11.001","journal-title":"Ophthalmol Retina"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-024-03338-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-024-03338-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-024-03338-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T15:39:48Z","timestamp":1741880388000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-024-03338-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,12]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3338"],"URL":"https:\/\/doi.org\/10.1007\/s10792-024-03338-9","relation":{},"ISSN":["1573-2630"],"issn-type":[{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,12]]},"assertion":[{"value":"1 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"427"}}